Palliative treatment of mammary cancer. Response of soft tissue, pleural and pulmonary disease.
D000315:Adrenalectomy; D000328:Adult; D000367:Age Factors; D000368:Aged; D001943:Breast Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D002369:Castration; D003520:Cyclophosphamide / Q000627:therapeutic use; D003907:Dexamethasone / Q000627:therapeutic use; D004967:Estrogens / Q000627:therapeutic use; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D008175:Lung Neoplasms / Q000628:therapy; D008207:Lymphatic Metastasis; D008875:Middle Aged; D009362:Neoplasm Metastasis; D010166:Palliative Care; D010997:Pleural Neoplasms / Q000628:therapy; D011241:Prednisone / Q000627:therapeutic use; D013738:Testolactone / Q000627:therapeutic use; D013899:Thoracic Neoplasms / Q000628:therapy
D004967:Estrogens; D013738:Testolactone; D003907:Dexamethasone; D003520:Cyclophosphamide; D005472:Fluorouracil; D011241:Prednisone